US9840710 - 12/12/2017 - Michelle Hastings - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Desease
US9827478B1 - 11/28/2017 - Bijan Najafi, et al. - Providing Visual Motion Feedback Based on Sensor Data
US9725429 B2 - 8/8/2017 - Grace Stutzmann - Furan-based Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release and Method for Treating Alzheimer's Disease with these Compounds
US9556434 - 1/31/2017 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome
US9532961 - 1/3/2017 - Darryl Peterson - A method and kit for administering gamma-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke
US9353371 - 5/31/2016 - Michelle Hastings, et al. - Antisense Compounds Targeting Genes Associated with usher syndrome
US9114112 - 8/25/2015 - Bruce Riser - CNN3 and CNN3 peptides and analogs thereof for therapeutic use
US9102645 - 8/11/2015 - Grace Stutzman - Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
US8979665B1 - 3/17/2015 - Bijan Najafi, et al. - Providing Motion Feedback Based on User Center of Mass
US8841436 - 9/23/2014 -Judith Potashkin, et al. - Screening, diagnosing, treating and prognosis of pathophysiologic status by RNA regulation
US8772468 - 7/8/2014 - Judith Potashkin - Splice variant specific messenger RNA transcripts as biomarkers of Parkinson's disease
US8753275B2 - 6/17/2014 - Bijan Najafi, et al. - Intelligent Device to Monitor And Remind Patients With Footwear, Walking Aids, Braces, Or Orthotics
US8648053 - 2/11/2014 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in USH1C as a therapeutic for usher syndrome
US8518886 - 8/27/2013 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke
US8518395 - 8/27/2013 - Bruce Riser - CCN3 peptides and analogs thereof for therapeutic use
US8133860 - 3/13/2012 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
US8105257 - 1/31/2012 - Erin Klein, et al. - Extremity stress attenuation modality with resistance-mechanism engaging member
US8067366 - 11/29/2011 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
US7956037 - 6/7/2011 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke
US7780949 - 8/24/2010 - Bruce Riser - Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
US7261887 - 8/28/2007 - Kwang-Poo Chang, Sujoy Dutta. - Leishmania as carriers for the delivery of proteins and peptides
17/371,427 - 7/9/2021 - Raul Gazmuri - Gliflozins and a Method for their Delivery during Resuscitation from Cardiac Arrest to Improve Survival Outcomes
17/274,981 - 3/10/2021 - Michelle Hastings, et al. - Compounds and Methods For Modulating CLN3 Expression
16/977,649 - 9/2/2020 - Michelle Hastings, et al. - Compounds and Methods for the Modulation of Amyloid Beta Precursor Protein
16/888576 - 5/29/2020 - Kwang Poo Chang - Immunotherapy of Solid Tumors by Vaccination with Transgenicleishmania Expressing Cancer Vaccines
16/511,103 - 7/15/2019 - Bruce Riser - CCN3 and CCN3 Peptides and Analogs Thereof for Therapeutic Use
PCT/EP2020/078295 - 10/8/2020 - Jun-Yong Choe, et al. - Variant of Gala Reductase and their Uses
16/536,981 - 8/9/2019 - Michelle Hastings, et al. - Antisense Compounds Targeted to CLN3 and Uses Thereof
16/414951 - 11/28/2019 - Joanna Dabrowska - System and Method for Determining a Discrimination Index for Fear-Potentiated Startle
